Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2
Detection Principle
NucleicAcid-PCR based
Target
M, S
Testing Method Category
PCR_KIT
Testing Method
kit
Testing Method - Additional Info
BioFire® Respiratory Panel 2.1 (RP2.1) against three other SARS CoV-2 EUA assays.
Reported Performance
PPA: 98 % ; NPA: 100 %
Sample Size
100 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements